In addition, expression of these target genes decreased meaningfully in the bortezomib-resistant and HRP2-knockdown (HRP2-KD) MM cells compared with their control group cells (Supplemental Figure 6, B and C). The gene discussed is HDGFL2; the disease is Miyoshi myopathy.